The United States Food and Drug Administration has approved the Harmony Transcatheter Pulmonary Valve System, the first non-surgical heart valve to treat pediatric and adult patients with congenital heart defects, which affect approximately 40,000 babies each year.1 The device is intended to improve blood flow to the lungs without requiringRead More →

When echocardiography results are unclear, fetal cardiovascular MRI (CMR) can provide valuable information about congenital heart defects, leading to changes in treatment or management decisions in more than 80% of cases, reports a new study. Not only could this imaging information be used to augment treatment for infants, a teamRead More →